| Value | ₹50.00 Cr |
|---|
NSE filing, NSE: SHALPAINTS. Summary written from the filing by ALFA Finder's alert engine.
Shalimar Paints Ltd: key numbers
- Share price
- ₹78.28
- Market cap
- ₹655.3 Cr
- Revenue (annual)
- ₹575.6 Cr
- Net profit (annual)
- ₹-64.95 Cr
- P/E (TTM)
- -7.5×Sector 43.7×
- Promoter holding
- 74.96%+0.00% QoQ
- FII holding
- 0.02%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shalimar Paints Ltd
All →Shalimar Paints Management Change
Shalimar Paints' non-executive director Abhijeet Jhawar resigned effective November 3, 2026, citing personal reasons. The board-level change carries no disclosed financial value.
Shalimar Paints Q2 FY27 Results: Net Loss of ₹32.5 Cr, Loss Widens
Shalimar Paints Ltd reported revenue from operations of ₹115.7 Cr (-13.5% YoY) and a net loss of ₹32.5 Cr for Q2 FY27.
- Key figure
- Net loss ₹32.5 Cr
Shalimar Paints Board Meeting Date
Shalimar Paints scheduled its Board meeting for October 28, 2026, to review Q2/H1 2026-27 unaudited results. The trading window will remain closed through October 30, 2026.
Shalimar Paints Other Announcement
Shalimar Paints filed its quarterly shareholding pattern for the period ended September 30, 2026, as required by regulatory disclosure norms.
Shalimar Paints Other Announcement
Shalimar Paints Limited submitted the quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the period ended September 30, 2026.
Shalimar Paints Annual General Meeting
Shalimar Paints held its 124th AGM on September 09, 2026, transacting ordinary and special business including financial statements and director re-appointment.
Other merger & restructuring announcements
All →Narayana Hrudayalaya Merger & Restructuring
Narayana Hrudayalaya's NCLT Bengaluru bench sanctioned the demerger of clinical services from its subsidiary NH Integrated Care. Order uploaded today; effectiveness awaits certified copy filings.
Abans Enterprises Merger & Restructuring
Abans Enterprises' board approved voluntary liquidation of wholly owned subsidiary AGJT, subject to shareholder approval. Completion is expected within one year.
- Execution
- Expected within one year, subject to approvals and statutory formalities
Max Estates Merger & Restructuring Worth ₹0.01 Cr
Max Estates will subscribe to 10,000 shares worth ₹1 lakh in a yet-to-be-incorporated real estate company. The entity awaits Ministry of Corporate Affairs approval.
- Value
- ₹0.01 Cr
Aurobindo Pharma Merger & Restructuring Worth ₹29 Cr
Aurobindo Pharma approved transferring 100% of Auro Pharma LLC, Russia, between wholly owned subsidiaries. Cash consideration is about INR 29 crore, subject to adjustments.
- Value
- ₹29.00 Cr
- Execution
- 60-90 days
Choice International Merger & Restructuring Worth ₹1.27 Cr
Choice International sold a unit or subsidiary to Arrowbridge Trade for Rs.1.275 Crore in cash. The buyer is unrelated and the deal is at arm's length.
- Value
- ₹1.27 Cr
Shringar House of Mangalsutra Merger & Restructuring Worth ₹5 Cr
Shringar House of Mangalsutra will incorporate a wholly owned jewellery subsidiary, subscribing Rs 5 Crore in cash. The subsidiary becomes a related party once formed.
- Value
- ₹5.00 Cr